Product Description
Anti-ITGA4+ITGB7 (Vedolizumab) -SMCC-DM1 ADC | ADC-W-2492 | Creative Biolabs
Short Description: This ADC product is comprised of an anti-ITGA4+ITGB7 monoclonal antibody conjugated via a SMCC linker to DM1
Status: In stock
Expected Delivery Time: 9-11Weeks